Jan 21, 2026 12:21PM
Jan 21, 2026 04:15AM
Jan 20, 2026 12:47PM
Jan 20, 2026 12:22PM
Jan 20, 2026 12:22PM
Jan 20, 2026 11:52AM
Jan 20, 2026 09:29AM Guggenheim Downgrades Rapt Therapeutics (RAPT) to Neutral
Jan 20, 2026 08:03AM
Jan 20, 2026 07:08AM
Jan 20, 2026 06:58AM
Jan 9, 2026 04:51AM
Dec 18, 2025 05:30AM
Oct 28, 2025 06:42AM
Oct 27, 2025 06:08AM Guggenheim Starts Rapt Therapeutics (RAPT) at Buy, PT $70
Oct 21, 2025 05:32AM
Oct 20, 2025 12:30PM
Oct 20, 2025 09:23AM
Oct 13, 2025 05:31AM
Sep 29, 2025 04:38PM
Sep 29, 2025 05:45AM
Sep 26, 2025 06:17AM Leerink Partners Upgrades Rapt Therapeutics (RAPT) to Outperform
Aug 8, 2025 06:28AM
Aug 7, 2025 09:38AM
Aug 7, 2025 05:22AM
Jul 30, 2025 02:28AM
Jul 10, 2025 06:42AM
Jun 23, 2025 08:04AM
Jun 13, 2025 09:00AM RAPT Therapeutics (RAPT) Sets June 16 as Effective Date of 1:8 Reverse Share Split
Jun 5, 2025 04:52PM
May 22, 2025 06:57AM
May 22, 2025 05:48AM
Mar 10, 2025 06:51AM
Jan 6, 2025 04:38PM
Dec 26, 2024 06:33AM
Dec 23, 2024 07:12AM RAPT Therapeutics (RAPT) Announces $150M Private Placement
Dec 23, 2024 07:01AM
Nov 25, 2024 06:52AM
Nov 12, 2024 04:54PM
Nov 12, 2024 04:08PM
Nov 12, 2024 04:04PM
Nov 11, 2024 11:45AM
Nov 11, 2024 08:04AM RAPT Therapeutics (RAPT): Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury
Aug 20, 2024 06:43AM
Aug 8, 2024 09:23AM

396,470 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All